MRNA May 2024 111.000 call
| Previous close | 30.19 |
| Open | 30.19 |
| Bid | 48.15 |
| Ask | 56.15 |
| Strike | 111.00 |
| Expiry date | 2024-05-24 |
| Day's range | 30.19 - 30.19 |
| Contract range | N/A |
| Volume | |
| Open interest | 49 |
Barrons.comModerna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Last year, Moderna began early-stage tests of a number of avian flu vaccines that target different strains of the virus.
Barrons.comCDC Confirms a Second Bird Flu Case in U.S. Dairy Worker. Vaccine Momentum Builds.
U.S. officials said Wednesday that a Michigan dairy worker had tested positive for avian influenza, the second known human case in the U.S. since the virus was detected in late March in cattle. The Centers for Disease Control and Prevention said that the patient only had eye symptoms, similar to the first known infected dairy worker, who developed conjunctivitis in Texas in March. The CDC said that it still considers the risk from the current outbreak to the general public to be low.
BloombergBird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks
(Bloomberg) -- Mounting cases of bird flu in humans is luring the day trading crowd to snap up stock in vaccine developers. It’s a familiar setup for industry veterans who have witnessed past trading frenzies at the first signs of an outbreak. Most Read from BloombergThese Flight Routes Suffer the World’s Worst TurbulenceCiti Trader Got 711 Warning Messages Before Sparking Flash CrashNvidia Forecast Shatters Estimates as AI Boom Stays StrongOne Dead After Singapore Air Flight Hit By Severe Turbu
